Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
about
Obstructive sleep apnea and asthmaDo mast cells link obesity and asthma?An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype.Asthma outcomes: biomarkersAlterations of the arginine metabolome in asthma.The isoprostanes--25 years laterObesity, airway hyperresponsiveness, and inflammation.Obesity, adipokines, and lung diseaseDoes obesity produce a distinct asthma phenotype?Update in asthma 2013Environmental perturbations: ObesityOnset of obesity in carboxypeptidase E-deficient mice and effect on airway responsiveness and pulmonary responses to ozoneAssociation of obstructive sleep apnea risk with asthma control in adults.Gene-gene and gene-environmental interactions of childhood asthma: a multifactor dimension reduction approach.Effect of antigen sensitization and challenge on oscillatory mechanics of the lung and pulmonary inflammation in obese carboxypeptidase E-deficient miceAirway and plasma leptin and adiponectin in lean and obese asthmatics and controlsObesity, asthma, and oxidative stress.Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammationMetabolic Syndrome Is Associated with Increased Oxo-Nitrative Stress and Asthma-Like Changes in Lungs.Relationship between body composition, inflammation and lung function in overweight and obese asthma.Metabolic origins of childhood asthma.Obesity, Nutrition, and Asthma in Children.Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype.Effects of obesity and weight loss on airway physiology and inflammation in asthma.Immunological characteristics and management considerations in obese patients with asthma.Correlation between oxidative stress and the NF-κB signaling pathway in the pulmonary tissues of obese asthmatic mice.Arginine and nitric oxide pathways in obesity-associated asthma.Role of obesity in asthma control, the obesity-asthma phenotype.The asthma phenotype in the obese: distinct or otherwise?Obesity and asthma: physiological perspectiveObesity, metabolic dysregulation and oxidative stress in asthma.Obesity-asthma association: is it explained by systemic oxidant stress?Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers.Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis.The many faces of asthma in obesity.Oxidative stress in airway diseases.Obesity and atopy.Emerging molecular phenotypes of asthma.Novel biomarkers for asthma stratification and personalized therapy.Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
P2860
Q26997776-8FAAAA28-5B6A-4E67-A441-86B5D9B37E9EQ27001152-1D211D72-9C88-4C52-8CC3-51237682727FQ30415302-E62B29D4-0177-4A05-A263-7EC8ABA4B766Q30425168-516647F8-9C19-401F-871B-F32D60288FC0Q30438259-33085022-F52A-4045-93E7-A866B8FEE3C5Q33601352-FC3E1395-CC61-487A-8DF1-8AAD42E86E4BQ33727992-44E1298C-9E18-4598-8F7D-A04B670B6C37Q33728020-4AB2936A-1F82-45F2-82E5-86F1D676F595Q33728026-FFF81C75-4213-4915-B120-90D70BBC970EQ33732168-EA532324-68AD-4E54-B30C-E800435A36B0Q33771557-E8BCF5B7-7B2C-43FF-A711-2E49826B16FEQ33917409-50089CBC-92A5-4E88-91D4-C4BB92A836FFQ34130706-7B5FE44B-E73C-4870-84E7-667C3F19E9A6Q34166205-C2299C5B-1828-429A-B32A-DC2ADD283986Q34201199-41D7B393-4582-4423-8703-3F058C7D676EQ34893354-BBD16666-72A0-4B9B-A498-2489073B52A6Q35013789-0DFBC408-C31C-47B9-B09E-B49C14FEE262Q35190104-877F830C-C240-4AE8-8DBD-F014F819550EQ35670336-E087A65E-D71F-475F-87E1-02A9E81846D3Q35897113-1B9F1729-083F-4F0C-BBB3-A0713685D30EQ35933300-E58E9003-2451-4AE7-8A01-58EE642F9A25Q36041393-72C4FB6B-14F4-4087-BED8-A771F11CF777Q36238208-812CC1E7-9CF5-4F6E-8F2B-4F14B4C9AC6AQ36413148-45398521-775E-479E-81E3-3EC0B5DCE45EQ36418444-47152FAE-D83D-4A33-B61D-47169B1DDAA6Q36520199-E2ACA3B6-FB25-4AC8-A425-65E09F0DEFEDQ36845120-CE4D1033-8AA2-46F1-9836-E5F7F0D898FAQ36848522-D1251222-9F06-4E33-822F-095021BBBB9CQ37002800-83CD13A5-366A-4802-A14B-58065ECA22B7Q37067683-769B69B0-1566-42D6-8397-2B6566D8A8A5Q37206475-1AF0CFEE-695C-4EF3-AD0A-958AB10339CDQ37406986-C8CBB893-6198-4059-AE80-1727FC0B9B5AQ37688530-9FF3D303-5B41-43F0-B696-AE4EBC363BF5Q37820124-B737DA02-F2A9-4682-BA78-2DC8B905D234Q38151619-490FCFFE-154D-432B-823F-4A084550A865Q38169242-C1CB583F-94D9-42AC-A012-04EE5E378524Q38260854-E1740471-142A-4DAD-B720-4282DF103788Q38261186-F688413C-1C16-40BF-BC40-8F3479D0FFF5Q38283811-E071A3F7-30A6-4AF8-928E-FDACC173D54FQ38528048-B91F43D6-A748-4F26-9789-D4D4C9D74981
P2860
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Body mass index is associated ...... d 8-isoprostanes in asthmatics
@ast
Body mass index is associated ...... d 8-isoprostanes in asthmatics
@en
type
label
Body mass index is associated ...... d 8-isoprostanes in asthmatics
@ast
Body mass index is associated ...... d 8-isoprostanes in asthmatics
@en
prefLabel
Body mass index is associated ...... d 8-isoprostanes in asthmatics
@ast
Body mass index is associated ...... d 8-isoprostanes in asthmatics
@en
P2093
P2860
P356
P1433
P1476
Body mass index is associated ...... d 8-isoprostanes in asthmatics
@en
P2093
Fernando Holguin
Gerald W Teague
Joel Mermis
LouAnn Brown
Mauricio Rojas
Samira Savill
Shireen Haque
Sumita Khatri
Sushma Komakula
P2860
P2888
P356
10.1186/1465-9921-8-32
P577
2007-04-16T00:00:00Z
P5875
P6179
1014370239